Ads
related to: ketamine depression clinical trials- Locate a Treatment Center
Locate Your Nearest Certified
SPRAVATO® Treatment Center
- Dosing & Administration
Find Dosing & Administration
Info for SPRAVATO®
- Save w/ SPRAVATO withMe
Eligible Patients Pay $10/Tx
2025 Additional Requirements Apply
- What is SPRAVATO®?
Learn More About What Makes
SPRAVATO® Treatment Different
- Prescribing Information
Find Full Prescribing Information
for SPRAVATO®
- Safety & Tolerability
Learn More About SPRAVATO®
Safety & Tolerability Data
- Locate a Treatment Center
Search results
Results From The WOW.Com Content Network
Similar research has shown that clinical trials of psilocybin have “produced promising results concerning the treatment of addiction, depression and end-of-life mood disorders,” according to ...
Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]
A new slow-release tablet form of ketamine, which can be safely taken at home, could help treat severe depression, according to a clinical trial. At-home ketamine tablet may alleviate symptoms of ...
The clinical development program for NV-5138 began with a Phase 1 trial initiated by Navitor Pharmaceuticals in 2018. [1] [7] This initial study was designed to evaluate the safety, tolerability, and pharmacokinetics of the compound in both healthy volunteers and patients diagnosed with TRD. [8] Following the Phase 1 trial,larger Phase 2 ...
A new study compares ketamine with electroconvulsive therapy in people with treatment-resistant depression. The researchers identify subsets of people who respond better to ketamine and vice versa.
Ketamine is a dissociative anesthetic used medically for induction and maintenance of anesthesia. It is also used as a treatment for depression and in pain management. [19] Ketamine is an NMDA receptor antagonist which accounts for most of its psychoactive effects. [20]
Ads
related to: ketamine depression clinical trials